Skip to main content

Table 1 Patients characteristics

From: Impact of bileaflet mitral valve prolapse on quantification of mitral regurgitation with cardiac magnetic resonance: a single-center study

 

All patients (n = 35)

No MR (n = 15)

Significant MR (n = 20)

p

Age (years)

44.0 ± 23.0

38.1 ± 19.1

48.5 ± 25.1

0.19

Height (cm)

174.5 ± 12.4

178.1 ± 13.2

171.9 ± 11.4

0.14

Weight (kg)

62.4 ± 15.9

64.5 ± 18.8

60.8 ± 13.7

0.5

BMI (kg/m2)

20.3 ± 3.8

20.1 ± 4.3

20.4 ± 3.4

0.82

LVEDV (ml)

155.4 ± 51.1

151.5 ± 58.3

158.4 ± 46.3

0.7

LVEDV index (ml/m2)

88.5 ± 22.8

83.4 ± 22.6

92.2 ± 22.8

0.27

LVESV uncorrected (ml)

53.3 ± 23.3

50.9 ± 25.6

55.0 ± 22.0

0.62

LVESV corrected (ml)

69.8 ± 28.4

65.3 ± 29.7

73.1 ± 27.8

0.43

LVEF standard (%)

66.4 ± 7.3

67.2 ± 7.1

65.7 ± 7.6

0.56

LVEF corrected (%)

55.6 ± 8.3

57.6 ± 7.2

54.1 ± 8.9

0.22

Prolapsed height (mm)

8.1 ± 2.8

7.6 ± 2.1

8.5 ± 3.2

0.32

Prolapsed volume (ml)

16.5 ± 8.7

14.4 ± 7.0

18.1 ± 9.6

0.22

RVEDV (ml)

140.1 ± 46.3

157.4 ± 55.6

127.2 ± 33.8

0.05

RVESV (ml)

68.6 ± 24.5

73.8 ± 28.7

64.7 ± 20.9

0.29

RVEF (%)

51.0 ± 6.6

53.5 ± 5.3

49.1 ± 7.0

0.05

Indication for CMR (n; %)

• Marfan syndrome

11 (31)

6 (40)

5 (25)

0.02

• MR quantification

9 (26)

0 (0)

9 (45)

 

• Ventricular arrhythmia

7 (20)

6 (40)

1 (5)

 

• Ischemia detection

5 (14)

2 (13)

3 (15)

 

• Suspicion of myocarditis

1 (3)

0 (0)

1 (5)

 

• Malformation syndromes

2 (6)

1 (7)

1 (5)